Charles J. Homcy

Filings by Charles J. Homcy span 5 companies, the busiest being BridgeBio Pharma, Inc., Global Blood Therapeutics, Inc. and Portola Pharmaceuticals Inc. The record holds 79 filings, for trades running from 17 June 2016 to 22 June 2026.

The open-market record consists of 30 sales worth €30.8M, with no purchase. The totals exclude 10 filings filed without an amount. Besides market trades, the filings include 16 share grants and 24 option exercises.

On 24 June 2026 came the latest disclosure, a share grant in BridgeBio Pharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.